Figure 3From: Early intervention in Alzheimer’s disease: a health economic study of the effects of diagnostic timing Sensitivity of net benefits obtained under a symptomatic treatment model to costing horizon and treatment effect size. Panel A: results when costing over 5, 10 and 20 years; Panel B: result of doubling or halving of treatment effect on MMSE score; Panel C: effect of mean cohort age at model start.Back to article page